Current Income Tax Expense (Benefit) of ALPINE IMMUNE SCIENCES, INC. from 31 Dec 2019 to 31 Mar 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Summary: ALPINE IMMUNE SCIENCES, INC. quarterly and annual Current Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2019 to 31 Mar 2024.
ALPINE IMMUNE SCIENCES, INC. Current Income Tax Expense (Benefit) for the quarter ending 31 Mar 2024 was $0.
ALPINE IMMUNE SCIENCES, INC. annual Current Income Tax Expense (Benefit) for 2023 was $51,000.
ALPINE IMMUNE SCIENCES, INC. annual Current Income Tax Expense (Benefit) for 2022 was $2,282,000.
ALPINE IMMUNE SCIENCES, INC. annual Current Income Tax Expense (Benefit) for 2021 was $129,000.
Source SEC data: View on sec.gov

Current Income Tax Expense (Benefit), Quarterly (USD)

Current Income Tax Expense (Benefit), Annual (USD)

ALPINE IMMUNE SCIENCES, INC. Quarterly Current Income Tax Expense (Benefit) (USD)

Period	Value	YoY Chg	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2024	$0	$0	01 Jan 2024	31 Mar 2024	10-Q	09 May 2024	2024	Q1
Q1 2023	$0	$0	01 Jan 2023	31 Mar 2023	10-Q	09 May 2024	2024	Q1
Q2 2022	$1,300,000		01 Apr 2022	30 Jun 2022	10-Q	14 Nov 2022	2022	Q3
Q1 2022	$0	$0	01 Jan 2022	31 Mar 2022	10-Q	11 May 2023	2023	Q1
Q1 2021	$0		01 Jan 2021	31 Mar 2021	10-Q	12 May 2022	2022	Q1

Period	Value	YoY Chg	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2023	$51,000	-$2,333,000	01 Jan 2023	31 Dec 2023	10-K	20 Mar 2024	2023	FY
2022	$2,282,000^*	+$2,153,000	01 Jan 2022	31 Dec 2022	10-K	20 Mar 2024	2023	FY
2021	$129,000	+$135,000	01 Jan 2021	31 Dec 2021	10-K	20 Mar 2024	2023	FY
2020	$6,000	-$6,000	01 Jan 2020	31 Dec 2020	10-K	23 Mar 2023	2022	FY
2019	$0		01 Jan 2019	31 Dec 2019	10-K	17 Mar 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.